Taylor Michael J, Weegman Bradley P, Baicu Simona C, Giwa Sebastian E
Sylvatica Biotech, Inc., North Charleston, South Carolina, USA.
Department of Mechanical Engineering, Carnegie Mellon University, Pittsburgh, Pennsylvania, USA.
Transfus Med Hemother. 2019 Jun;46(3):197-215. doi: 10.1159/000499453. Epub 2019 Jun 4.
In this concept article, we outline a variety of new approaches that have been conceived to address some of the remaining challenges for developing improved methods of biopreservation. This recognizes a true renaissance and variety of complimentary, high-potential approaches leveraging inspiration by nature, nanotechnology, the thermodynamics of pressure, and several other key fields. Development of an organ and tissue supply chain that can meet the healthcare demands of the 21st century means overcoming twin challenges of (1) having enough of these lifesaving resources and (2) having the means to store and transport them for a variety of applications. Each has distinct but overlapping logistical limitations affecting transplantation, regenerative medicine, and drug discovery, with challenges shared among major areas of biomedicine including tissue engineering, trauma care, transfusion medicine, and biomedical research. There are several approaches to biopreservation, the optimum choice of which is dictated by the nature and complexity of the tissue and the required length of storage. Short-term hypothermic storage at temperatures a few degrees above the freezing point has provided the basis for nearly all methods of preserving tissues and solid organs that, to date, have proved refractory to cryopreservation techniques successfully developed for single-cell systems. In essence, these short-term techniques have been based on designing solutions for cellular protection against the effects of warm and cold ischemia and basically rely upon the protective effects of reduced temperatures brought about by Arrhenius kinetics of chemical reactions. However, further optimization of such preservation strategies is now seen to be restricted. Long-term preservation calls for much lower temperatures and requires the tissue to withstand the rigors of heat and mass transfer during protocols designed to optimize cooling and warming in the presence of cryoprotective agents. It is now accepted that with current methods of cryopreservation, uncontrolled ice formation in structured tissues and organs at subzero temperatures is the single most critical factor that severely restricts the extent to which tissues can survive procedures involving freezing and thawing. In recent years, this major problem has been effectively circumvented in some tissues by using ice-free cryopreservation techniques based upon vitrification. Nevertheless, despite these promising advances there remain several recognized hurdles to be overcome before deep-subzero cryopreservation, either by classic freezing and thawing or by vitrification, can provide the much-needed means for biobanking complex tissues and organs for extended periods of weeks, months, or even years. In many cases, the approaches outlined here, including new underexplored paradigms of high-subzero preservation, are novel and inspired by mechanisms of freeze tolerance, or freeze avoidance, in nature. Others apply new bioengineering techniques such as nanotechnology, isochoric pressure preservation, and non-Newtonian fluids to circumvent currently intractable problems in cryopreservation.
在这篇概念文章中,我们概述了为应对生物保存改良方法开发中一些尚存挑战而构思出的多种新方法。这标志着一个真正的复兴以及各种相互补充、具有高潜力的方法,这些方法从自然、纳米技术、压力热力学以及其他几个关键领域汲取灵感。建立一个能够满足21世纪医疗保健需求的器官和组织供应链,意味着要克服两大挑战:一是拥有足够的这些救生资源,二是拥有将它们储存和运输以用于各种应用的手段。每一个挑战都有独特但相互重叠的物流限制,影响着移植、再生医学和药物研发,并且在生物医学的主要领域(包括组织工程、创伤护理、输血医学和生物医学研究)中存在共同的挑战。生物保存有多种方法,其最佳选择取决于组织的性质和复杂性以及所需的储存时长。在略高于冰点的温度下进行短期低温储存,为几乎所有保存组织和实体器官的方法提供了基础,而迄今为止,这些方法对于为单细胞系统成功开发的冷冻保存技术而言一直难以适用。本质上,这些短期技术一直基于设计细胞保护方案以抵御热缺血和冷缺血的影响,并且基本上依赖于化学反应的阿伦尼乌斯动力学所带来的降温保护作用。然而,现在看来这种保存策略的进一步优化受到了限制。长期保存需要低得多的温度,并且要求组织在旨在优化存在冷冻保护剂时的冷却和升温过程的方案中承受热传递和质量传递的严苛条件。现在人们认识到,就目前的冷冻保存方法而言,零下温度下结构化组织和器官中不受控制的冰晶形成是严重限制组织在涉及冻融过程中存活程度的最关键因素。近年来,通过基于玻璃化的无冰冷冻保存技术,在一些组织中已有效规避了这一主要问题。尽管有这些有前景的进展,但在深度低温冷冻保存(无论是通过经典的冻融还是玻璃化)能够为长时间(数周、数月甚至数年)生物储存复杂组织和器官提供急需的手段之前,仍有几个公认的障碍需要克服。在许多情况下,这里概述的方法,包括尚未充分探索的零下高保存新范式,都是新颖的,并且受到自然界中耐冻或避冻机制的启发。其他方法则应用新的生物工程技术,如纳米技术、等容压力保存和非牛顿流体,以规避目前冷冻保存中难以解决的问题。